Amicus Therapeutics Correlations
FOLD Stock | USD 6.29 0.07 1.13% |
The current 90-days correlation between Amicus Therapeutics and Halozyme Therapeutics is 0.28 (i.e., Modest diversification). The correlation of Amicus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Amicus Therapeutics Correlation With Market
Very weak diversification
The correlation between Amicus Therapeutics and DJI is 0.47 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Moving against Amicus Stock
0.69 | KB | KB Financial Group | PairCorr |
0.58 | KMDA | Kamada | PairCorr |
0.58 | SHG | Shinhan Financial Earnings Call This Week | PairCorr |
0.56 | AVAL | Grupo Aval | PairCorr |
0.55 | WF | Woori Financial Group Earnings Call Today | PairCorr |
0.39 | PFE | Pfizer Inc | PairCorr |
0.35 | EVGN | Evogene | PairCorr |
0.35 | FNMFO | Federal National Mortgage Earnings Call This Week | PairCorr |
0.33 | CGEN | Compugen | PairCorr |
0.31 | INCR | INC Research Holdings | PairCorr |
0.31 | NKTR | Nektar Therapeutics | PairCorr |
0.78 | DIS | Walt Disney | PairCorr |
0.76 | MSFT | Microsoft Earnings Call This Week | PairCorr |
0.75 | IBM | International Business Earnings Call Today | PairCorr |
0.72 | CSCO | Cisco Systems Sell-off Trend | PairCorr |
0.68 | AXP | American Express | PairCorr |
0.56 | AA | Alcoa Corp | PairCorr |
0.46 | CVX | Chevron Corp | PairCorr |
0.4 | INTC | Intel Earnings Call Tomorrow | PairCorr |
0.38 | T | ATT Inc Earnings Call Today | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Amicus Stock performing well and Amicus Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Amicus Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
HALO | 1.99 | (0.16) | (0.02) | 0.04 | 4.92 | 2.90 | 42.68 | |||
AGIO | 1.86 | 0.42 | 0.21 | 0.57 | 1.66 | 4.21 | 9.77 | |||
INSM | 2.17 | 0.53 | 0.19 | 0.88 | 1.96 | 4.10 | 31.65 | |||
RARE | 2.43 | (0.52) | 0.00 | (0.30) | 0.00 | 5.12 | 33.92 | |||
PTCT | 2.02 | (0.12) | (0.02) | 0.05 | 4.30 | 4.05 | 22.27 | |||
TGTX | 2.30 | (0.24) | (0.05) | 0.00 | 3.52 | 4.35 | 17.61 | |||
ACAD | 2.09 | 0.59 | 0.32 | 0.89 | 1.27 | 3.01 | 31.37 |
Amicus Therapeutics Corporate Management
Anthony Sileno | Senior Sciences | Profile | |
David Clark | Chief Officer | Profile | |
Patrik Esq | Global Officer | Profile | |
Michael Keavany | Senior Business | Profile | |
Patrik Florencio | Global VP | Profile | |
Simon Harford | Chief Officer | Profile |